NORTHERN TRUST CORP - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 30 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$95,000
+58.3%
46,664
+11.1%
0.00%
Q1 2022$60,000
-11.8%
42,0000.0%0.00%
Q4 2021$68,000
-49.3%
42,0000.0%0.00%
Q3 2021$134,000
-21.6%
42,000
+21.2%
0.00%
Q2 2021$171,000
-20.1%
34,658
+33.7%
0.00%
Q1 2021$214,000
+613.3%
25,923
+60.1%
0.00%
Q4 2020$30,000
+66.7%
16,192
-22.1%
0.00%
Q3 2020$18,00020,7820.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 373,867$1,847,0000.43%
NewGen Asset Management Ltd 200,000$988,0000.37%
SABBY MANAGEMENT, LLC 174,900$864,0000.12%
Kepos Capital LP 100,000$494,0000.04%
Hudson Bay Capital Management LP 380,404$1,879,0000.02%
Paloma Partners Management Co 139,081$687,0000.01%
Cutler Group LLC / CA 24,495$121,0000.01%
Cutler Group LLC / CA 35,000$36,0000.00%
Stratos Wealth Partners, LTD. 15,543$77,0000.00%
Lake Point Wealth Management 1,000$5,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders